Abstract:Although ATP-sensitive potassium (K(ATP)) channel openers, e.g., minoxidil and diazoxide, can induce hair growth, their mechanisms require clarification. Improved drugs are needed clinically. but the absence of a good bioassay hampers research. K(ATP) channels from various tissues contain subtypes of the regulatory sulfonylurea receptor, SUR, and pore-forming, K(+) inward rectifier subunits, Kir6.X, giving differing sensitivities to regulators. Therefore, the in vitro effects of established potassium channel o… Show more
“…Evidence now indicates that the mechanism of action of minoxidil, or minoxidil sulfate, which is a metabolite of minoxidil, is through stimulation of hair growth by opening ATPsensitive potassium channels within the dermal papilla [45], indicating that the effect is on the hair follicle itself, rather than the surrounding microenvironment. This is further supported as other potassium channel openers such as diazoxide are capable of increasing hair growth rates in the hair follicle organ culture model, indicating a similar mode of action for promoting hair growth [46]. Moreover, the effects of both minoxidil and diazoxide on hair growth can both be abrogated by coculture with a potassium channel inhibitor, tolbutamide [46].…”
Section: Drug Discovery Using Hair Follicle Organ Culturesmentioning
confidence: 64%
“…This is further supported as other potassium channel openers such as diazoxide are capable of increasing hair growth rates in the hair follicle organ culture model, indicating a similar mode of action for promoting hair growth [46]. Moreover, the effects of both minoxidil and diazoxide on hair growth can both be abrogated by coculture with a potassium channel inhibitor, tolbutamide [46].…”
Section: Drug Discovery Using Hair Follicle Organ Culturesmentioning
Many of the current drug therapies for androgenetic alopecia were discovered serendipitously, with hair growth observed as an off-target effect when drugs were used to treat a different disorder. Subsequently, several studies using cultured cells have enabled identification of hair growth modulators with similar properties to the currently available drugs, which may also provide clinical benefit. In situations where the current therapeutics do not work, follicular unit transplantation is an alternative surgical option. More recently, the concept of follicular cell implantation, or hair follicle neogenesis, has been attempted, exploiting the inherent properties of cultured hair follicle cells to induce de novo hair growth in balding scalp. In this review, we discuss both the advances in cell culture techniques that have led to a wider range of potential therapeutics to promote hair growth, in addition to detailing current knowledge on follicular cell implantation, and the challenges in making this approach a reality.
“…Evidence now indicates that the mechanism of action of minoxidil, or minoxidil sulfate, which is a metabolite of minoxidil, is through stimulation of hair growth by opening ATPsensitive potassium channels within the dermal papilla [45], indicating that the effect is on the hair follicle itself, rather than the surrounding microenvironment. This is further supported as other potassium channel openers such as diazoxide are capable of increasing hair growth rates in the hair follicle organ culture model, indicating a similar mode of action for promoting hair growth [46]. Moreover, the effects of both minoxidil and diazoxide on hair growth can both be abrogated by coculture with a potassium channel inhibitor, tolbutamide [46].…”
Section: Drug Discovery Using Hair Follicle Organ Culturesmentioning
confidence: 64%
“…This is further supported as other potassium channel openers such as diazoxide are capable of increasing hair growth rates in the hair follicle organ culture model, indicating a similar mode of action for promoting hair growth [46]. Moreover, the effects of both minoxidil and diazoxide on hair growth can both be abrogated by coculture with a potassium channel inhibitor, tolbutamide [46].…”
Section: Drug Discovery Using Hair Follicle Organ Culturesmentioning
Many of the current drug therapies for androgenetic alopecia were discovered serendipitously, with hair growth observed as an off-target effect when drugs were used to treat a different disorder. Subsequently, several studies using cultured cells have enabled identification of hair growth modulators with similar properties to the currently available drugs, which may also provide clinical benefit. In situations where the current therapeutics do not work, follicular unit transplantation is an alternative surgical option. More recently, the concept of follicular cell implantation, or hair follicle neogenesis, has been attempted, exploiting the inherent properties of cultured hair follicle cells to induce de novo hair growth in balding scalp. In this review, we discuss both the advances in cell culture techniques that have led to a wider range of potential therapeutics to promote hair growth, in addition to detailing current knowledge on follicular cell implantation, and the challenges in making this approach a reality.
“…Because minoxidil has stimulated hair regrowth in several forms of alopecia, different speculations regarding its mechanism of action have been forwarded. These include immunomodulation (Fiedler and Buys, 1987, Fiedler and Buys, 1988), targeting specific follicular potassium channels (Davies et al, 2005) or induction of PGE2 synthesis in the dermal papilla fibroblasts (Michelet et al, 1997). …”
Heterocyclic N-oxides have emerged as potent compounds with anticancer, antibacterial, antihypertensive, antiparasitic, anti-HIV, anti-inflammatory, herbicidal, neuroprotective, and procognitive activities. The N-oxide motif has been successfully employed in a number of recent drug development projects. This review surveys the emergence of this scaffold in the mainstream medicinal chemistry with a focus on the discovery of the heterocyclic N-oxide drugs, N-oxide-specific mechanisms of action, drug-receptor interactions and synthetic avenues to these compounds. As the first review on this subject that covers the developments since 1950s to date, it is expected that it will inspire wider implementation of the heterocyclic N-oxide motif in the rational design of new medicinal agents.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.